AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-15864636_ITM" title="Facts and information about Enbrel indication expanded.(PRODUCTS)">Enbrel indication expanded.(PRODUCTS)</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Enbrel indication expanded.(PRODUCTS)
Enbrel (etanercept) is indicated for reducing signs and symptoms, inhibiting the progression of structural damage of active arthritis, and improving physical ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Enbrel indication expanded.(PRODUCTS)(Brief Article)
- Magazine article from: Internal Medicine News August 1, 2005 700+ words
Enbrel (etanercept) is indicated for the improvement of physical function in patients who have psoriatic arthritis, a long-lasting condition that causes skin rashes and joint inflammation. Contact Wyeth Pharmaceuticals by visiting www.enbrel.com or by calling 888-436-2735.
- Enbrel indication expanded.(Products)(Brief Article)
- Magazine article from: Family Practice News October 1, 2005 700+ words
Enbrel (etanercept) is now indicated for the improvement of physical function in patients with psoriatic arthritis. For more information on this medication, contact Amgen Inc. and Wyeth Pharmaceuticals by visiting www.enbrel.com or by calling 888-436-2735.
- CHEMICAL MARKET REPORTER: AHP/Immunex abandon new Enbrel indication.
- News wire article from: Chemical Business Newsbase April 10, 2001 700+ words
Attempts to develop Enbrel (etanercept) for the indication of chronic heart failure have been abandoned by American Home Products and Immunex. Website: httpwww.chemexpo.com/cmronline
- Indication Expanded for Colorectal Cancer Drug.(Brief Article)(Statistical Data...
- Magazine article from: Family Practice News MECHCATIE, ELIZABETH June 15, 2000 700+ words
The indications for the antineoplastic drug Camptosar have been expanded to include first-line therapy for patients who have metastatic colorectal cancer, with the agent used in combination with another antineoplastic agent, 5-fluorcyuracil/leucovorin (5-FU/LV). Camptosar was initially approved in
- Amitiza indication expanded.(NEWS FROM THE FDA)(Brief article)
- Magazine article from: Internal Medicine News June 1, 2008 700+ words
The chronic idiopathic constipation drug Amitiza (lubiprostone) was approved by the Food and Drug Administration for irritable bowel syndrome with constipation in women 18 years and older, making it the only prescription drug available for irritable bowel syndrome with constipation. The addition of
- Lipitor indication expanded.(PRODUCTS)(Brief Article)
- Magazine article from: Internal Medicine News December 1, 2005 700+ words
Lipitor (atorvastatin calcium) is indicated to reduce the risk of stroke and myocardial infarction in people with type 2 diabetes without evidence of heart disease but with other risk factors. For more information, contact Pfizer Inc. by visiting www.lipitor.com or calling 800-879-3477.
- Press Release: Schering-Plough announces Nasonex indication expanded to include...
- News wire article from: Asia Africa Intelligence Wire July 19, 2002 700+ words
(From Chemical Business NewsBase: Press Release) Schering-Plough Corp announced that the US Food and Drug Administration (FDA) has approved the expansion of the indication of Nasonex (mometasone furoate monohydrate) for the treatment of seasonal and perennial nasal allergy symptoms to include
- PEM not hindered by breast density, hormonal status: indicated for women with...
- Magazine article from: OB GYN News Wendling, Patrice January 1, 2009 700+ words
...system. PEM is currently indicated for women with breast cancer. Dr. Schilling said she would like to see the indication expanded in the future to include high-risk patients. PEM holds promise, but current evidence is too limited to speculate...